72
Participants
Start Date
December 31, 2009
Primary Completion Date
August 31, 2010
Study Completion Date
AZD3043
Intravenous, single dose
Infusion, single dose
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY